Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

14,246 total articles

Raymond James: U.S. Petroleum Stocks Rose Sharply, Surprising Expectations

Raymond James: U.S. Petroleum Stocks Rose Sharply, Surprising Expectations

Raymond James flagged the latest U.S. Department of Energy weekly supply figures as bearish versus market expectations after total petroleum inventories increased by 7.4 million barrels. Crude stocks rose by 6.9 million barrels, gasoline stocks fell 2.6 million barrels, and distillate stocks climbed 3.0 million barrels. Refinery utilization ticked …

Stocks Climb as Oil Retreats From Recent Spike, Volatility and Yields Ease

Stocks Climb as Oil Retreats From Recent Spike, Volatility and Yields Ease

U.S. equities rose Wednesday as oil prices cooled from multi-day highs, easing some immediate pressure on markets. Volatility and Treasury yields pulled back but remain elevated. Recent data showed a surprise monthly increase in core import prices, while hotel revenue per available room continued to show year-over-year gains. Geopolitical uncertain…

BofA Initiates Coverage on Bicara Therapeutics, Shares Tick Higher

BofA Initiates Coverage on Bicara Therapeutics, Shares Tick Higher

Bicara Therapeutics shares rose after BofA Securities began coverage with a Buy rating and a $35 price target. The initiation emphasized the promise of Bicara’s lead candidate, ficerafusp alfa, in head and neck cancer based on early phase 1b signals and key opinion leader feedback. The company is also advancing studies in other tumor types, with in…

Fincantieri steps up M&A push to expand underwater capabilities

Fincantieri steps up M&A push to expand underwater capabilities

Fincantieri said it is actively exploring mergers and acquisitions to accelerate growth in underwater operations, while Romania and Greece have expressed interest in joining the European Patrol Corvette project. The moves reflect the group’s strategic shift to diversify away from traditional surface-vessel construction and pursue subsea defense and…

Tel Aviv Stocks End Higher as Insurance, Biomed and Financials Lead Gains

Tel Aviv Stocks End Higher as Insurance, Biomed and Financials Lead Gains

Israel's equity benchmark finished higher on Wednesday as strength in the Insurance, Biomed and Financials sectors pushed the TA 35 up 0.97% at the close in Tel Aviv. Insurers recorded the session's largest advances, while renewable energy and select technology-related names posted the biggest declines. Market breadth was mixed, and commodities and…

Corcept Therapeutics Soars After FDA Clears Relacorilant for Specific Platinum-Resistant Ovarian Cancers

Corcept Therapeutics Soars After FDA Clears Relacorilant for Specific Platinum-Resistant Ovarian Cancers

Shares of Corcept Therapeutics climbed about 40% after the U.S. Food and Drug Administration granted approval for relacorilant (Lifyorli) used in combination with nab-paclitaxel to treat adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The decision, completed 2.5 months ahead of the target date, is su…

Wolfe Research Raises GM to Outperform, Points to Select Buying Opportunities in Auto Sell-Off

Wolfe Research Raises GM to Outperform, Points to Select Buying Opportunities in Auto Sell-Off

Wolfe Research upgraded General Motors to Outperform after a recent sectorwide pullback created what the firm views as attractive entry points. The note, authored by Emmanuel Rosner, also elevated BorgWarner and reiterated a positive view on Aptiv while warning of execution risk at Ford. Wolfe adjusted production and commodity assumptions and now s…